S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.

Autor: Tu, Xiaoxuan1,2 (AUTHOR), Chen, Longxian2,3 (AUTHOR), Zheng, Yi1 (AUTHOR), Mu, Chenglin2 (AUTHOR), Zhang, Zhiwei2,4 (AUTHOR), Wang, Feiyu2,3 (AUTHOR), Ren, Yiqing1 (AUTHOR), Duan, Yingxin3 (AUTHOR), Zhang, Hangyu1 (AUTHOR), Tong, Zhou1 (AUTHOR), Liu, Lulu1 (AUTHOR), Sun, Xunqi1 (AUTHOR), Zhao, Peng1 (AUTHOR), Wang, Lie5 (AUTHOR), Feng, Xinhua3,6 (AUTHOR) fenglab@zju.edu.cn, Fang, Weijia1 (AUTHOR) weijiafang@zju.edu.cn, Liu, Xia2,7 (AUTHOR) xia.liu@zju.edu.cn
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 3/8/2024, Vol. 43 Issue 1, p1-22. 22p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje